NR4A3 deficiency in CD8+ T cells improves adoptive T cell therapy of cancer
L. Odagiu, S. Mezrag, D. Maurice De Sousa, S. Boulet, N. Labrecque
NR4A3 deficiency in CD8+ T cells enhances tumor control in adoptive cell therapy, correlating with increased effector function and distinct progenitor populations.
bioRxiv · Apr 21, 2023 · PreprintImmunology